Multi-Targeted Inhibition of an Essential Tetrameric Enzyme from Drug -Resistant Streptococcus pneumonie.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/628681

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Streptococcus pneumoniae is an significant human pathogen which causes several diseases including pneumonia and meningitis. Treatment of infection involves the use of antibiotics such as penecillin, however, resistant strains are now emerging. This project will address the real need to develop new antibiotics targeting this organism. This is essentially a drug discovery project which exploits a novel means to target Streptococcus pneumoniae.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2013

Funding Scheme: Project Grants

Funding Amount: $534,313.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Bacteriology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Antibiotic Resistance | Antibiotic Therapy | Antibiotics | Bacterial Infection | Bacterial Pathogen | Community Health | Infectious Diseases | Streptococcal Disease | Streptococcus

Related Links